# Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors

> **NCT01510730** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 855 (actual)

## Conditions studied

- Gastric Tumor
- Helicobacter Pylori
- Endoscopic Resection
- Metachronous Neoplasms

## Interventions

- **DRUG:** eradication treatment of Helicobacter pylori infection

## Key facts

- **NCT ID:** NCT01510730
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 855 (ACTUAL)
- **Last updated:** 2012-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01510730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01510730, "Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01510730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*